Satoshi Kamata
President chez JMTC Enzyme Corp.
Profil
Satoshi Kamata is currently the President & Representative Director at JMTC Enzyme Corp.
He previously held the position of President & Representative Director at Ise Chemicals Corp.
and President at AGC, Inc. (Japan).
He also served as an Independent Outside Director at CDS Co., Ltd.
Postes actifs de Satoshi Kamata
| Sociétés | Poste | Début |
|---|---|---|
JMTC Enzyme Corp.
 JMTC Enzyme Corp. Chemicals: Major DiversifiedProcess Industries JMTC Enzyme Corp. produces D-lactic acid of Takamitsu purification made from plant-derived ingredients using its own genetic modification yeast. This acid can be used as a raw material for the intermediate body of medical drugs and as a monomer for biodegradable resin bioplastics (plant-derived resin) poly lactic acid control PDLA (poly D-lactic acid). The Japanese company also sells D-lactic acid reagent under the brand name Fujifilm Wako Pure Drug. | President | 01/03/2016 |
Anciens postes connus de Satoshi Kamata
| Sociétés | Poste | Fin |
|---|---|---|
| AGC INC. | President | - |
| CDS CO.,LTD. | Director/Board Member | - |
| ISE CHEMICALS CORPORATION | President | - |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| AGC INC. | Consumer Durables |
| ISE CHEMICALS CORPORATION | Process Industries |
| CDS CO.,LTD. | Technology Services |
| Entreprise privées | 1 |
|---|---|
JMTC Enzyme Corp.
JMTC Enzyme Corp. Chemicals: Major DiversifiedProcess Industries JMTC Enzyme Corp. produces D-lactic acid of Takamitsu purification made from plant-derived ingredients using its own genetic modification yeast. This acid can be used as a raw material for the intermediate body of medical drugs and as a monomer for biodegradable resin bioplastics (plant-derived resin) poly lactic acid control PDLA (poly D-lactic acid). The Japanese company also sells D-lactic acid reagent under the brand name Fujifilm Wako Pure Drug. | Process Industries |
